Aerospace
Cellular Propulsion Systems (CPS)
Patented microcellular propellant: 15% Isp gain, inherently safe, scalable.
Phase I complete; Phase II production-scale planned
Technology Readiness
$10.2B+
Market
Dual patents
IP / Differentiator
Aerospace
Sector
Executive Summary
CPS's patented microcellular solid propellant technology and Supercritical Fluids manufacturing process delivers 15% specific impulse gains with inherently safe, scalable production, replacing 60-year-old batch-mix propellant manufacturing.
Strategic Advantages
- ▸Dual patents: microcellular architecture + SCF manufacturing
- ▸15% Isp gain with inherent safety through polymer barriers
- ▸Integration with OSS mass-production facility
- ▸Phase I R&D validated at University of South Florida
Market Opportunity
$3.2B propellant within $6.6B propulsion market growing at 6–9% CAGR
Financial Detail — NC-9 Data Room
Detailed financial projections, valuation, and capital requirements for CPS are available to qualified investors in the NC-9 Data Room.
Investor InquiryCross-Venture Synergies
- Integration with OSS mass-production facility